AHIA National Conference 2006

Stretching The Boundaries
Private Health Insurance Reforms: Opportunities and Challenges

31st October - 2 November 2006

Conference Details

  • AHIA National Conference 2006 Program At A Glance

    Conference Presentations

    See below. Please refer back to this page for regular updates.


  • SESSION
    TOPIC
    SPEAKER
    OVERVIEW
    PRESENTATION
    DAY ONE
    1
    Recognising Individuality through Insurance
    Hon Jeffrey G Kennett AC, Chairman, beyondblue
     
    Not Available
    2
    Industry Views on the Implementation of the Private Health Insurance Reforms

    Hon Dr Michael Armitage, Chief Executive Officer, AHIA

    The impending reforms to the Private Health Insurance legislation are potentially the most significant changes to the delivery of healthcare in Australia in several decades. It is clear that the manner in which the reforms are implemented by different industry sectors will determine the eventual value of the reforms to the Australian health consumer.

    This session will provide an opportunity for varied Industry Sectors to discuss what they see as the outcomes of the implementation of the reforms.

    TBA

    Ms Christine Gee, President APHA

    Dr Mukesh Haikerwal, President, Australian Medical Association

    TBA
    Mr David Meldrum, CEO Advanced Community Care Association
    3
    Making Sense of Consumer Research

    Mr Tony Quint, General Manager, IPSOS

     

     
     

    Ms Samantha Gavel, Acting Private Health Insurance Ombudsman

    Mr Mark Textor, Principal, Crosby Textor

    TBA
    4
    New Technologies and Challenges

    Prof Ian Olver, Chief Executive Officer, The Cancer Council Australia

    Consumers are becoming more and more demanding of the health care system as technology becomes more sophisticated. Increasingly available expertise and modern therapies are leading to an impending dramatic rise in costs over the horizon.

    This session will examine the science behind some of the medical advances, and will provide an opportunity to gauge the cost implications for consumers, the Government, and the whole health sector.

     

    Prof Stephen Graves, Director, National Joint Replacement Registry

    Prof Simon Stewart, Head of the Preventative Cardiology Division of the Baker Heart Institute
    5
    Giving Back to the Community - Health Fund Foundations
    Prof Robert Graham, Executive Director, Victor Chang Cardiac Research Institute; Head, Molecular Cardiology Program; Des Renford Professor of Medicine, University of New South Wales

    A number of private health insurers have established entities with the aim of funding and promoting health and medical research in Australia.

    The ahm Health and Medical Research Fund, the HCF Health and Medical Research Foundation and the MBF Foundation have all been established with the aim of funding and supporting Australian health and medical research, the outcomes of which are designed to benefit not only those with Private Health Insurance but the community as a whole.

    Research funding commitments in excess of $10m have been made by these organisations in the last twelve months. Speakers on the program are all researches whose work has benefited from funding and support provided by these organisations.

    Stem Cells for Heart Disease: hype or hope?


    (14 MB ppt)

    Prof Johanna Westbrook, Deputy Director, Centre for Health Informatics, University of New South Wales

    Clinical Errors: Their Causes and Frequency in Australian Hospitals

    (2 MB ppt)

     

    Ms Leanne Pethick, Founder, depressionNet.com.au

    dNet Work Centre


    (235 KB ppt)

    DAY TWO
    6
    Generation X and Generation Y - Their Hot Buttons
    Ms Avril Henry, AH Revelations

     

    Not Available
    7
    An Investment Outlook for the Healthcare Sector: Analysts' Corner
    Mr John Goss, Principal Economist, AIHW

     

    Healthcare spending - Private Health Insurance in perspective

    As important a component as it is, Private Health Insurance remains a relatively small and constricted source of funding Australia burgeoning healthcare expenditure. In fact, its relative role has actually declined in recent years notwithstanding increased PHI participation within the population.

    This session will examine trends in healthcare expenditure and possible implications for private funding and PHI insurers.

     

    (812 KB ppt)

    Mr Jon Gidney, JP Morgan Managing Director Investment Banking, JP Morgan

     

    This Creature Called Mutuality

    For an industry dominated by mutual corporations, there is surprisingly little discourse around the ongoing relevance of this structure.

    This session will face the history and rationale behind mutuality, the pros and cons of mutuality and discuss why and how many companies have sought to demutualise.

     

    (236 KB ppt)

    8
    Quality and Safety
    Dr Diana Horvath AO, Chief Executive Officer, Australian Commission on Safety and Quality in Health Care

    Quality in Healthcare has traditionally involved processes such as accreditation, and risk management through systems and activities focused on limiting adverse events. Whilst addressing the human and financial costs of adverse events is an industry priority, it is also time for us to look at the quality of health care from a value perspective - is the care appropriate and effective?

    This session addresses the challenge for the industry to move to a more long term quality approach that ensures the investment in health care delivers better health outcomes.

    Dr Andrew Vallance-Owen, Deputy Chairman of the BUPA Foundation and the BUPA's Group Medical Director
    Prof Guy Maddern, Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIPS-S), Adelaide and Department of Surgery, University of Adelaide
    TBA